PharmaGossipAtLast

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Friday, September 13, 2013

Shouldn’t Hip & Knee Replacements Come With Warranties?

Posted on 12:53 AM by Unknown


(Great Beyond)

(Great Beyond)

Most new products, from cheapo wristwatches to new cars, often come with manufacturers’ warranties. But that isn’t the case for most hip and knee implants, meaning that a growing number of Americans are having expensive devices put in their bodies without any written assurance from the manufacturers.

More than 4 million Americans currently have knee implants, and that number is expected to grow as life expectancy rates improve. In 2011 alone, there were 711,000 knee replacements performed. That same year, around 500,000 Americans received hip replacement implants. The combined annual demand for these two surgeries is expected to reach 4 million by 2030, and more than half of those patients will be under 65 years old, meaning they will likely be living with the implants for quite some time.

Yet, of the six major manufacturers of knee replacement implants — Biomet, DePuy, Smith & Nephew, Stryker, Wright, Zimmer — only one (Biomet) offers any sort of warranty, and that’s only on one partial knee implant model.

According to our coworkers at Consumers Union, between 2003 and 2013, these manufacturers recalled 709 different devices and components. During that same time period, these companies recalled 578 different recalls related to hip implants.

In both types of implant, the overwhelming majority of recalls were considered Class II recalls, which the FDA describes as “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”

But more than 10% of all hip implant recalls were categorized as Class I, described by the FDA as “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.” Most of the Class I hip implant recalls were for products made by Stryker.

Some patients with metal-on-metal hip implants have experienced debilitating symptoms — including cardiomyopathy and neurological problems — from debris that flakes off the device over time. The FDA has thus proposed a more rigorous review process for metal-on-metal hip implants.

As we’ve mentioned in the past, FDA approval process for many new implanted devices is streamlined so that each new product need not undergo individual review it the manufacturer can demonstrate that the device is “substantially equivalent” to one that’s already on the market. This is similar to the process FDA uses for giving the go-ahead to cigarettes, which implies the agency holds cancer-causing products to the same standards as implanted medical devices.

Given that most new hip and knee implants are very similar to what’s already being used, the devices are fast-tracked without ever being tested to see if they are safe and effective.

In a 2012 poll, the overwhelming majority of American consumers said they believed in a rigorous review process for new devices, and Consumers Union was one of several patient safety groups that urged Congress to require more pre-market testing of implanted devices during last year’s reauthorization of the Medical Device User Fee Act. Alas, patient advocacy once again lost out to the deeper pockets of the well-heeled medical device industry lobbyists.

You may not care about people with implanted devices and you may say that warranties are unwarranted because many patients are not going out of pocket for these surgeries (or the seemingly inevitable replacement surgeries), but for every failed implant that hits the market, there is an impact on the average consumer.

Even if the patient isn’t paying for the surgery, someone is footing the bill — and it’s often quite a big bill. This is compounded each time there is a replacement, as it often costs more to remove and replace an implant than it did to put it in initially. Patients often end up in the hospital for a longer period of time following these later surgeries.

Consumers Union estimates that revisions to hip and knee replacements cost hundreds of millions of dollars a year. Insurance companies aren’t going to shrug that much money off, especially when it seems likely to increase in the coming decade.

“Patients have a right to know how long medical device manufacturers are willing to stand by their products,” said Lisa McGiffert, director of Consumers Union’s Safe Patient Project. “While patients may be told by their surgeon how long a device can be expected to last, they rarely get a guarantee in writing since most hip and knee implants do not come with a warranty.”

“Medical device companies claim that current law provides adequate protection for patients and that their implants are dependable and safe,” said McGiffert. “If that’s the case, they should have no objection to offering warranties to back up those claims. Patients and taxpayers shouldn’t be on the hook for the cost of replacing devices when they fail.”

CU has already written to the manufacturers, urging each to provide a 20-year warranty with their products. The letters also clarified that an ideal warranty would:
*Cover the full cost of replacing the flawed device, including the device, surgeon and hospital costs as well as related patient out-of-pocket costs.
*Establish a clear system for patients to use, including a toll-free phone line and a registration number to track the claims process, with physicians charging the device company, not the patient.
*Not eliminate the patient’s right to sue if they use a warranty.
*Provide the patient with a full explanation if a warranty claim is denied and an appeals process for denials.
*Not disqualify patients across the board if they have specific diseases or illnesses that are not related to the failure of the device.

For those who believe that manufacturers should include warranties with their implanted medical devices, the folks at CU’s Safer Patient project have put together this handy online form to let you voice your opinion to these companies’ chief executives.

http://consumerist.com/2013/09/12/shouldnt-hip-knee-replacements-come-with-warranties/?

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Beautiful Barcelona! - Gedeon Richter ruled in breach of ABPI code
    LYNNE TAYLOR Gedeon Richter (UK) has breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, and has brough...
  • GlaxoChinaGate contd. - Bwaaa!
    China Drug Probe 'Unfair,' Euro Group Says Thu, 09/05/2013 - 8:30am Foreign companies believe they are unfairly being singled out fo...
  • Another day, another J&J recall ... Mold found in schizophrenia drug forces Johnson & Johnson recall
    By  Bloomberg News  on September 11, 2013 at 5:25 PM, updated  September 11, 2013 at 5:27 PM Johnson & Johnson has recalled 5,000 vials ...
  • AllTrials Update
    Dear Friends Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The Europea...
  • Hurrah!
    Press Release 11 September 2013 FOR IMMEDIATE RELEASE The HRA is now implementing its plans for ensuri...
  • Advertisement
    The book addresses, in great, evidence-based detail, a general system failure caused by widespread crime, corruption, bribery and impotent d...
  • Of pigs and penicillin
    Extended Withdrawal Needed to Avoid Penicillin G Residues News US - A minimum 51-day withdrawal is necessary if penicillin G is used in pigs...
  • The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007
    . The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simm...
  • Wrigley holds off on caffeinated gum as FDA reviews caffeine
    By Melissa Healy 7:54 p.m. EDT, May 9, 2013 Less than a week after the Food and Drug Administration announced that it would investigate the ...
  • Petition by Professor David Healy - please sign if you agree
    Let us see Drug Data! Drug hazards are not “trade secrets”! Drug companies maximize the sales of new drugs by hyping their benefits while do...

Categories

  • Abbott (1)
  • alltrials (1)
  • alosetron (1)
  • AstraZeneca (1)
  • Baxter (1)
  • big pharma (2)
  • bribery (7)
  • Champix (1)
  • chantix (1)
  • china (7)
  • Clinical Trails (1)
  • Clinical Trial (1)
  • corruption (5)
  • Dan Markingson (1)
  • Dan Markingson Death (1)
  • diabetes (2)
  • Diovan (1)
  • EFPIA (1)
  • glaxo (11)
  • Glaxo China bribery corruption (1)
  • gsk (7)
  • hongbao (1)
  • insurance (1)
  • Januvia (1)
  • johnson and johnson (1)
  • Lotronex (1)
  • Mefloquine (1)
  • Mental Health (1)
  • Merck (2)
  • Novartis (1)
  • pancreas (1)
  • pfizer (1)
  • pharma (1)
  • pharmaceuticals (1)
  • PhRMA (1)
  • quetiapine (1)
  • Sanofi (2)
  • scandal (1)
  • seroquel (1)
  • side effects (1)
  • suvorexant (1)
  • ucb (1)
  • Valsartan (1)
  • Zaltrap (1)

Blog Archive

  • ▼  2013 (300)
    • ▼  September (40)
      • Petition by Professor David Healy - please sign if...
      • Advertisement
      • 1boringoldman explains data transparency
      • AllTrials Update
      • Ketamine, A Darling of the Club Scene, Inspires Ne...
      • Shouldn’t Hip & Knee Replacements Come With Warran...
      • Wise words
      • GlaxoChinaGate contd. - German drug giant Bayer la...
      • Winning friends
      • Richard Smith: Is the pharmaceutical industry like...
      • Another day, another J&J recall ... Mold found in ...
      • Hurrah!
      • Pain drugs will need new warnings to alert patient...
      • Implementation of a publication strategy in the co...
      • GlaxoChinaGate contd. - GSK affirms China plans, d...
      • Dementia campaign could lead to over-diagnosis, sa...
      • Of Conflicts and Clinical Trials: Researchers Repo...
      • Slumdog Clinical Trials contd - Kenyan patients be...
      • Beautiful Barcelona! - Gedeon Richter ruled in bre...
      • Now I wonder how GSK will find the cash to pay for...
      • GlaxoChinaGate contd. - Rick Tang explains China's...
      • Deaths soar as Britain turns into nation of prescr...
      • Another J&J recall - Infant Motrin due to plastic...
      • GlaxoChinaGate contd. Now US prosecutors add China...
      • The Lancet has formally retracted the Jikei Heart ...
      • A Glut of Antidepressants
      • GlaxoChinaGate contd. - Bwaaa!
      • Takeda Put Actos Sales Ahead of Safety, Lawyer Tel...
      • It's never good when authorities talk openly of im...
      • Of pigs and penicillin
      • Riots, Rage, and Resistance: A Brief History of Ho...
      • GlaxoChinaGate contd. Reforms urged for pharma ind...
      • FDA probe Gilenya
      • GlaxoChinaGate contd.. - now HR are spotlighted. C...
      • Richard Smith, Former Editor-in-Chief, BMJ reviews...
      • Peter C Gøtzsche, Professor, Director, MD, DrMedSc...
      • Wrigley holds off on caffeinated gum as FDA review...
      • Ooh la la
      • Deadly Medicines and Organized Crime by Peter Gøtz...
      • You are welcome
    • ►  August (70)
    • ►  July (104)
    • ►  June (81)
    • ►  May (5)
Powered by Blogger.